//]]>

Sarcopenia – Age-Related Muscle Wasting and Weakness (Record no. 18537)

000 -LEADER
fixed length control field 04233nam a22004575i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310150249.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 101130s2011 ne | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789048197132
978-90-481-9713-2
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number R-RZ
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 610
Edition number 23
264 #1 -
-- Dordrecht :
-- Springer Netherlands,
-- 2011.
912 ## -
-- ZDB-2-SBL
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lynch, Gordon S.
Relator term editor.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Sarcopenia – Age-Related Muscle Wasting and Weakness
Medium [electronic resource] :
Remainder of title Mechanisms and Treatments /
Statement of responsibility, etc edited by Gordon S. Lynch.
300 ## - PHYSICAL DESCRIPTION
Extent XIII, 480p.
Other physical details online resource.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1.Overview -- 2. Molecular mechanisms of muscle wasting in cancer and ageing: cachexia versus sarcopenia -- 3. Age-related remodeling of neuromuscular junctions -- 4.Motor unit remodeling during aging -- 5. Age-related decline in actomyosin structure and function -- 6. Excitation-contraction coupling in aged skeletal muscle -- 7. Mitochondrial function in aging skeletal muscle -- 8. Fibrosis and skeletal muscle aging -- 9. Nuclear apoptosis and sarcopenia -- 10. Age-related changes in the molecular regulation of skeletal muscle mass -- 11. Genetic variation and skeletal muscle traits: implications for sarcopenia -- 12. Proteomic profiling of aged skeletal muscle -- 13. Aging, exercise and muscle protein metabolism -- 14. Reactive oxygen species generation and skeletal muscle wasting – implications for sarcopenia -- 15. Exercise as a countermeasure for sarcopenia -- 16. Role of contraction-induced injury in age-related muscle wasting and weakness -- 17. Role of IGF-I signaling in age-related changes in skeletal muscle -- 18. Role of myostatin and TGF-beta signaling in skeletal muscle growth and development: implications for sarcopenia -- 19. β-Adrenergic signaling in sarcopenia and other muscle wasting disorders.
520 ## - SUMMARY, ETC.
Summary, etc Some of the most serious consequences of aging are its effects on skeletal muscle. ‘Sarcopenia’, the progressive age-related loss of muscle mass and associated muscle weakness, renders frail elders susceptible to serious injury from sudden falls and fractures and at risk for losing their functional independence. Not surprisingly, sarcopenia is a significant public health problem throughout the developed world. There is an urgent need to better understand the neuromuscular mechanisms underlying age-related muscle wasting and to develop therapeutic strategies that can attenuate, prevent, or ultimately reverse sarcopenia. Significant research and development in academic and research institutions and in pharmaceutical companies is being directed to sarcopenia and to related health issues in order to develop and evaluate novel therapeutics. This book provides the latest information on sarcopenia from leading international researchers studying the cellular and molecular mechanisms underlying age-related changes in skeletal muscle and identifies strategies to combat sarcopenia and related muscle wasting conditions and neuromuscular disorders. The book provides a vital resource for researchers and practitioners alike, with information relevant to gerontologists, geriatricians, sports medicine physicians, physiologists, neuroscientists, cell biologists, endocrinologists, physical therapists, allied health and musculoskeletal practitioners, strength and conditioning specialists, athletic trainers, and students of the medical and biomedical sciences.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element Geriatrics.
Topical term or geographic name as entry element Sports medicine.
Topical term or geographic name as entry element Cytology.
Topical term or geographic name as entry element Biomedicine.
Topical term or geographic name as entry element Biomedicine general.
Topical term or geographic name as entry element Geriatrics/Gerontology.
Topical term or geographic name as entry element Cell Biology.
Topical term or geographic name as entry element Sports Medicine.
Topical term or geographic name as entry element Medicine/Public Health, general.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9789048197125
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-90-481-9713-2
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-08AUM Main Library2014-04-08 2014-04-08 E-Book   AUM Main Library610

Languages: 
English |
العربية